Benda Pharmaceutical, a China-based pharmaceutical company producing both Gendicine, the world's first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced its Jiangling plant has received approval from the State Food and Drug Administration to re-initiate production of its primary product line.

Original URL: Click here to visit original article
Copyright China Sourcing News